Skip to main content
. 2020 Oct 2;10:568809. doi: 10.3389/fonc.2020.568809

Figure 2.

Figure 2

Comparison of PD-L1 expression in each subgroup. (A) Age (<70 years vs. 70 years), (B) sex (male vs. female), (C) intravesical chemotherapy prior to VENTANA (no vs. yes), (D) systemic chemotherapy prior to VENTANA (no vs. yes), (E) specimen acquisition site (lower tract vs. upper tract vs. metastatic site), (F) time from tissue acquisition to VENTANA test (<1 month vs. ≥1 month), and (G) metastatic status (no vs. lymph node only vs. distant organ metastasis).